SARS-CoV-2 Mpro-IN-19 (compound MPI94) is a SARS-CoV-2 MPro inhibitor with the IC50 of 0.096 µM. SARS-CoV-2 Mpro-IN-19 can be used for study of COVID-19[1].
Molecular Weight:
503.59
Formula:
C29H33N3O5
Target:
SARS-CoV
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted